Advertisement
Screener

Y-mAbs Therapeutics, Inc. Stock-Based Compensation

Y-mAbs Therapeutics, Inc. Stock-Based Compensation

Y-mAbs Therapeutics, Inc. reported Stock-Based Compensation of $6.24 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2025-08-08

  • Y-mAbs Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $2.90M, a 15.62% decline year-over-year.
  • Y-mAbs Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $3.34M, a 13.13% decline year-over-year.
  • Y-mAbs Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-12-31 was $3.08M, a 1.41% decline year-over-year.
  • Y-mAbs Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-09-30 was $4.20M, a 74.07% increase year-over-year.
  • Y-mAbs Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $14.56M, a 0.73% increase from fiscal 2023.
  • Y-mAbs Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $14.45M, a 43.55% decline from fiscal 2022.
  • Y-mAbs Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $25.60M, a 32.42% increase from fiscal 2021.
  • Y-mAbs Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $19.33M, a 19.83% increase from fiscal 2020.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2025-06-30$2.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$6.24M
10-Q · filed 2025-08-08
$9.32M
derived: sum of 3 quarters · filed 2025-08-08
$13.52M
derived: sum of 4 quarters · filed 2025-08-08
2025-03-31$3.34M
10-Q · filed 2025-05-13
$6.42M
derived: sum of 2 quarters · filed 2025-05-13
$10.62M
derived: sum of 3 quarters · filed 2025-05-13
$14.05M
derived: sum of 4 quarters · filed 2025-08-08
2024-12-31$3.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04
$7.27M
derived: sum of 2 quarters · filed 2025-03-04
$10.71M
derived: sum of 3 quarters · filed 2025-08-08
$14.56M
10-K · filed 2025-03-04
2024-09-30$4.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$7.63M
derived: sum of 2 quarters · filed 2025-08-08
$11.48M
10-Q · filed 2024-11-08
$14.60M
derived: sum of 4 quarters · filed 2025-08-08
2024-06-30$3.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$7.29M
10-Q · filed 2025-08-08
$10.41M
derived: sum of 3 quarters · filed 2025-08-08
$12.82M
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$3.85M
10-Q · filed 2025-05-13
$6.97M
derived: sum of 2 quarters · filed 2025-05-13
$9.38M
derived: sum of 3 quarters · filed 2025-05-13
$12.99M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$3.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04
$5.53M
derived: sum of 2 quarters · filed 2025-03-04
$9.15M
derived: sum of 3 quarters · filed 2025-03-04
$14.45M
10-K · filed 2025-03-04
2023-09-30$2.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$6.03M
derived: sum of 2 quarters · filed 2024-11-08
$11.33M
10-Q · filed 2024-11-08
$14.87M
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30$3.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12
$8.92M
10-Q · filed 2024-08-12
$12.46M
derived: sum of 3 quarters · filed 2024-08-12
$15.80M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31$5.30M
10-Q · filed 2024-05-07
$8.84M
derived: sum of 2 quarters · filed 2024-05-07
$12.18M
derived: sum of 3 quarters · filed 2024-05-07
$25.82M
derived: sum of 4 quarters · filed 2024-05-07
2022-12-31$3.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$6.88M
derived: sum of 2 quarters · filed 2024-02-29
$20.51M
derived: sum of 3 quarters · filed 2024-02-29
$25.60M
10-K · filed 2024-02-29
2022-09-30$3.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$16.97M
derived: sum of 2 quarters · filed 2023-11-13
$22.07M
10-Q · filed 2023-11-13
$26.97M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$13.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$18.72M
10-Q · filed 2023-08-10
$23.63M
derived: sum of 3 quarters · filed 2023-08-10
$28.53M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$5.09M
10-Q · filed 2023-05-08
$10.00M
derived: sum of 2 quarters · filed 2023-05-08
$14.90M
derived: sum of 3 quarters · filed 2023-05-08
$19.73M
derived: sum of 4 quarters · filed 2023-05-08
2021-12-31$4.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$9.81M
derived: sum of 2 quarters · filed 2023-03-30
$14.64M
derived: sum of 3 quarters · filed 2023-03-30
$19.33M
10-K · filed 2023-03-30
2021-09-30$4.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
$9.73M
derived: sum of 2 quarters · filed 2022-11-07
$14.43M
10-Q · filed 2022-11-07
$22.76M
derived: sum of 4 quarters · filed 2022-11-07
2021-06-30$4.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$9.53M
10-Q · filed 2022-08-08
$17.86M
derived: sum of 3 quarters · filed 2022-08-08
$21.00M
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31$4.70M
10-Q · filed 2022-05-09
$13.03M
derived: sum of 2 quarters · filed 2022-05-09
$16.17M
derived: sum of 3 quarters · filed 2022-05-09
$18.62M
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31$8.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$11.47M
derived: sum of 2 quarters · filed 2022-03-01
$13.92M
derived: sum of 3 quarters · filed 2022-03-01
$16.14M
10-K · filed 2022-03-01
2020-09-30$3.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$5.59M
derived: sum of 2 quarters · filed 2021-11-04
$7.80M
10-Q · filed 2021-11-04
$9.28M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$2.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$4.67M
10-Q · filed 2021-08-09
$6.14M
derived: sum of 3 quarters · filed 2022-03-01
$7.49M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$2.21M
10-Q · filed 2021-05-06
$3.69M
derived: sum of 2 quarters · filed 2022-03-01
$5.03M
derived: sum of 3 quarters · filed 2022-03-01
$6.00M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$2.82M
derived: sum of 2 quarters · filed 2022-03-01
$3.79M
derived: sum of 3 quarters · filed 2022-03-01
$4.66M
10-K · filed 2022-03-01
2019-09-30$1.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$2.32M
derived: sum of 2 quarters · filed 2020-11-05
$3.18M
10-Q · filed 2020-11-05
$3.67M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$971.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$1.83M
10-Q · filed 2020-08-06
$2.33M
derived: sum of 3 quarters · filed 2020-08-06
$2.73M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$864.00K
10-Q · filed 2020-05-07
$1.36M
derived: sum of 2 quarters · filed 2020-05-07
$1.75M
derived: sum of 3 quarters · filed 2020-05-07
$2.66M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$495.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$890.00K
derived: sum of 2 quarters · filed 2020-03-12
$1.79M
derived: sum of 3 quarters · filed 2020-03-12
$1.97M
10-K · filed 2020-03-12
2018-09-30$395.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
$1.30M
derived: sum of 2 quarters · filed 2019-11-13
$1.47M
10-Q · filed 2019-11-13
$1.63M
derived: sum of 4 quarters · filed 2019-11-13
2018-06-30$904.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$1.08M
10-Q · filed 2019-08-14
$1.24M
derived: sum of 3 quarters · filed 2019-08-14
2018-03-31$172.00K
10-Q · filed 2019-05-10
$335.00K
derived: sum of 2 quarters · filed 2019-05-10
2017-12-31$163.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22
$609.00K
10-K · filed 2019-03-22
2017-09-30$446.00K
10-Q · filed 2018-11-13